Unravelling the Inflammatory Processes in the Early Stages of Diabetic Nephropathy and the Potential Effect of (Ss)-DS-ONJ
- PMID: 35955585
- PMCID: PMC9368839
- DOI: 10.3390/ijms23158450
Unravelling the Inflammatory Processes in the Early Stages of Diabetic Nephropathy and the Potential Effect of (Ss)-DS-ONJ
Abstract
Inflammatory processes play a central role in the pathogenesis of diabetic nephropathy (DN) in the early stages of the disease. The authors demonstrate that the glycolipid mimetic (Ss)-DS-ONJ is able to abolish inflammation via the induction of autophagy flux and provokes the inhibition of inflammasome complex in ex vivo and in vitro models, using adult kidney explants from BB rats. The contribution of (Ss)-DS-ONJ to reducing inflammatory events is mediated by the inhibition of classical stress kinase pathways and the blocking of inflammasome complex activation. The (Ss)-DS-ONJ treatment is able to inhibit the epithelial-to-mesenchymal transition (EMT) progression, but only when the IL18 levels are reduced by the treatment. These findings suggest that (Ss)-DS-ONJ could be a novel, and multifactorial treatment for DN.
Keywords: (Ss)-DS-ONJ; autophagy; diabetic nephropathy; epithelial mesenchymal transition; inflammation.
Conflict of interest statement
The authors declare no conflict of interest.
Figures











Similar articles
-
Adult kidney explants is a physiologic model for studying diabetic nephropathy.Life Sci. 2022 Jul 1;300:120575. doi: 10.1016/j.lfs.2022.120575. Epub 2022 Apr 25. Life Sci. 2022. PMID: 35472452
-
Complanatoside A targeting NOX4 blocks renal fibrosis in diabetic mice by suppressing NLRP3 inflammasome activation and autophagy.Phytomedicine. 2022 Sep;104:154310. doi: 10.1016/j.phymed.2022.154310. Epub 2022 Jul 5. Phytomedicine. 2022. PMID: 35843189
-
Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4/NF-κB signaling.Phytomedicine. 2019 Apr;57:203-214. doi: 10.1016/j.phymed.2018.12.021. Epub 2018 Dec 17. Phytomedicine. 2019. PMID: 30785016
-
Targeting the NLRP3 Inflammasome in Diabetic Nephropathy.Curr Med Chem. 2021;28(42):8810-8824. doi: 10.2174/0929867328666210705153109. Curr Med Chem. 2021. PMID: 34225600 Review.
-
Pyroptosis in diabetes and diabetic nephropathy.Clin Chim Acta. 2022 Jun 1;531:188-196. doi: 10.1016/j.cca.2022.04.011. Epub 2022 Apr 13. Clin Chim Acta. 2022. PMID: 35427562 Review.
Cited by
-
The updated development of blood-based biomarkers for Huntington's disease.J Neurol. 2023 May;270(5):2483-2503. doi: 10.1007/s00415-023-11572-x. Epub 2023 Jan 24. J Neurol. 2023. PMID: 36692635 Free PMC article. Review.
-
Systemic immune indicators for predicting renal damage in newly diagnosed type 1 diabetic children.World J Diabetes. 2025 May 15;16(5):104482. doi: 10.4239/wjd.v16.i5.104482. World J Diabetes. 2025. PMID: 40487601 Free PMC article.
-
Exploring a Novel Anti-Inflammatory Therapy for Diabetic Retinopathy Based on Glyco-Zeolitic-Imidazolate Frameworks.Pharmaceutics. 2025 Jun 17;17(6):791. doi: 10.3390/pharmaceutics17060791. Pharmaceutics. 2025. PMID: 40574103 Free PMC article.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous